Acacia Res-Acacia (ACTG) 4.53 $ACTG Acacia Subsidiary

New Post Public Reply Private Reply Replies (0) Message Board

Jun 23, 2016 at 2:06 AM

Acacia Res-Acacia (ACTG) 4.53 $ACTG

Acacia Subsidiary Signs Settlement and Patent License Agreement with American Gem Society and American Gem Society Laboratories, LLC
BusinessWire - Mon Jun 20, 5:00AM CDT
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Diamond Grading Technologies, LLC. subsidiary has signed a settlement and patent license agreement with American Gem Society and American Gem Society Laboratories, LLC. The agreement resolves litigation that was pending in the United States District Court for the Eastern District of Texas.
ACTG: 4.53 (-0.14)

Acacia Research Has Returned 29.9% Since SmarTrend Recommendation (ACTG)
Comtex SmarTrend(R) - Tue Jun 07, 1:37PM CDT
SmarTrend identified an Uptrend for Acacia Research (NASDAQ:ACTG) on March 21st, 2016 at $3.98. In approximately 3 months, Acacia Research has returned 29.89% as of today's recent price of $5.17.
ACTG: 4.53 (-0.14)

Uptrend Call Working As Acacia Research Stock Rises 31.4% (ACTG)
Comtex SmarTrend(R) - Tue May 31, 12:56AM CDT
SmarTrend identified an Uptrend for Acacia Research (NASDAQ:ACTG) on March 21st, 2016 at $3.98. In approximately 2 months, Acacia Research has returned 31.41% as of today's recent price of $5.23.
ACTG: 4.53 (-0.14)

Acacia Research (ACTG) is in Overbought Territory: What's Next?
Zacks Equity Research - Zacks Investment Research - Fri May 27, 8:17AM CDT
Acacia Research Corporation (ACTG) has moved higher as of late, but there could definitely be trouble on the horizon for this company.
ACTG: 4.53 (-0.14)

Upgrade Alert for Acacia Research (ACTG)
Comtex SmarTrend(R) - Tue May 24, 3:01AM CDT
Acacia Research (NASDAQ:ACTG) was upgraded from Market Perform to Outperform at Northland today. The stock closed yesterday at $5.08 on volume of 613,000 shares, above average daily volume of 505,000. In the past 52 weeks, shares of Acacia Research have traded between a low of $2.82 and a high of $10.86 and closed yesterday at $5.08, which is 80% above that low price. Over the past week, the 200-day moving average (MA) has gone down 1.3% while the 50-day MA has advanced 1.7%.
ACTG: 4.53 (-0.14)

Uptrend Call Working As Acacia Research Stock Rises 26.8% (ACTG)
Comtex SmarTrend(R) - Mon May 23, 1:12PM CDT
SmarTrend identified an Uptrend for Acacia Research (NASDAQ:ACTG) on March 21st, 2016 at $3.98. In approximately 2 months, Acacia Research has returned 26.76% as of today's recent price of $5.05.
ACTG: 4.53 (-0.14)

Acacia Research (ACTG) is Overbought: Is A Drop Coming?
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 8:50AM CDT
Acacia Research Corp (ACTG) has moved higher as of late, but there could definitely be trouble on the horizon for this company
ACTG: 4.53 (-0.14)

Xerox (XRX) Misses on Q1 Earnings, Split Likely in 2016
Supriyo Bose - Zacks Investment Research - Mon Apr 25, 9:39AM CDT
Xerox Corporation (XRX) reported relatively modest first-quarter 2016 results with adjusted earnings (from continuing operations) of 22 cents per share compared with 24 cents in the year-ago quarter.
PFMT: 1.62 (+0.01), ACTG: 4.53 (-0.14), XRX: 9.78 (-0.05), PFSW: 10.66 (-0.07)

Acacia Research reports 1Q loss
Automated Insights - Thu Apr 21, 3:21PM CDT
NEWPORT BEACH, Calif. (AP) _ Acacia Research Corp. (ACTG) on Thursday reported a loss of $10 million in its first quarter.
ACTG: 4.53 (-0.14)

Acacia Research Reports First Quarter Financial Results
BusinessWire - Thu Apr 21, 3:00PM CDT
Acacia Research Corporation(1) (Nasdaq: ACTG) today reported results for the three months ended March 31, 2016.
ACTG: 4.53 (-0.14)

Domtar Provides Sneak Peek into First-Quarter 2016 Results
Zacks Equity Research - Zacks Investment Research - Mon Apr 18, 1:19PM CDT
Domtar Corporation (UFS), a leading fiber-based technology company, recently provided an update on its first quarter 2016 financial performance.
ACTG: 4.53 (-0.14), UFS: 36.69 (-0.36), FBR: 7.73 (-0.24)

Healthcare Services Q1 Earnings in Line, Dividend Raised
Zacks Equity Research - Zacks Investment Research - Wed Apr 13, 9:00AM CDT
Healthcare Services Group, Inc. (HCSG) reported first-quarter 2016 net income of 26 cents per share, in line with the Zacks Consensus Estimate.
VEC: 26.56 (+0.16), ACTG: 4.53 (-0.14), PRGX: 5.21 (-0.03), HCSG: 39.65 (-0.24)

What Falling Estimates & Price Mean for Everi Holdings (EVRI)
Zacks Equity Research - Zacks Investment Research - Wed Apr 13, 8:07AM CDT
Everi Holdings has witnessed a significant price decline in the past four weeks and negative estimate revisions, making it time for investors to sell it off
ACTG: 4.53 (-0.14), EVRI: 1.59 (-0.01)

Ocean Tomo Announces Completion of over $650 Million in Intellectual Property Transaction Volume
PRWeb - Tue Apr 12, 3:46PM CDT
Ocean Tomo, LLC, the intellectual capital merchant banc™ firm, announced today updated performance of the Ocean Tomo Transactions Business Unit. Ocean Tomo has served as a trusted advisor to both large and small operating company patent owners, successfully closing a number of transactions with cumulative transaction value in excess of $650 million.
ACTG: 4.53 (-0.14)

Acacia Research Names Frank E. Walsh, III to Its Board of Directors
BusinessWire - Thu Apr 07, 5:00AM CDT
Acacia Research Corporation (NASDAQ: ACTG) announced today that Frank E. Walsh, III has joined its Board of Directors.
ACTG: 4.53 (-0.14), FCCY: 12.27 (-0.13)

US Ecology (ECOL) to Divest Non-Core Asset USE Augusta
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 2:30PM CDT
US Ecology, Inc. (ECOL), a renowned North American firm, recently announced the strategic sale of its non-hazardous solid and liquid waste processing unit, USE Augusta
CBZ: 10.55 (-0.17), ECOL: 46.14 (-0.02), ACTG: 4.53 (-0.14), WM: 63.06 (+0.33)

Acacia Research to Release First Quarter Financial Results and Host Conference Call
BusinessWire - Wed Apr 06, 5:00AM CDT
Acacia Research Corporation (NASDAQ: ACTG) announced today it will release its first quarter financial results on Thursday, April 21, 2016. Results will be released at 4:00 PM (EDT) / 1:00 PM (PDT).
ACTG: 4.53 (-0.14)

The Zacks Analyst Blog Highlights: Acacia Research, CalAmp, Renewable Energy Group and Sucampo Pharmaceuticals
Zacks Equity Research - Zacks Investment Research - Fri Apr 01, 8:30AM CDT
The Zacks Analyst Blog Highlights: Acacia Research, CalAmp, Renewable Energy Group and Sucampo Pharmaceuticals
REGI: 8.58 (+0.17), ACTG: 4.53 (-0.14), CAMP: 14.40 (+0.04), SCMP: 10.80 (+0.15)

Acacia Subsidiary Signs Patent License Agreement with Ericsson Inc. and Telefonaktiebolaget LM Ericsson
BusinessWire - Fri Apr 01, 5:00AM CDT
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Adaptix, Inc. subsidiary has signed a patent license agreement with Ericsson, Inc. and Telefonaktiebolaget LM Ericsson. The agreement resolves litigation that was pending in the United States District Court for the Eastern District of Texas.
ACTG: 4.53 (-0.14)

Acacia Subsidiary Enters into Settlement and Patent License Agreement with ViewSonic Corporation
BusinessWire - Fri Apr 01, 4:59AM CDT
April 1, 2016 - Acacia Research Corporation (NASDAQ: ACTG) announced today that its Nexus Display Technologies LLC subsidiary has entered into a settlement and patent license agreement with ViewSonic Corporation. The agreement resolves litigation that was pending in the United States District Court for the Central District of California.
ACTG: 4.53 (-0.14)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

OneOdio Showcases Innovation at IFA 2026 in Berlin

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Protecting Teeth: Insights from Endodontist Dr. Joubert

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Damp or Dry: The Battle for Healthy Air in Colorado

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Ajman Spotlights Tourism at Arabian Travel Market 2026

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

USPS Honors 150 Years of the U.S. Coast Guard Academy

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

D-Wave Faces Legal Questions After CFO Exit and Losses

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...